Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hirsch

Showing results (391-400 of 686) with videos related to

Pageof 69
Sort By:
Transplantation and Cellular Therapy|January 19, 2024
Differential Association between Blood Glucose Levels and Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation Based on Presence or Absence of Preexisting DiabetesNahid Rashid, Ted Gooley, Michael Boeckh, et al.
Diabetes Care|February 1, 1990
Failure of nocturnal hypoglycemia to cause daytime hyperglycemia in patients with IDDMI B Hirsch, L J Smith, C E Havlin, et al.
Diagnostic Microbiology and Infectious Disease|November 8, 2011
A model to predict mortality following Pseudomonas aeruginosa bacteremiaElizabeth B Hirsch, Jessica M Cottreau, Kai-Tai Chang, et al.
Nature|March 7, 1998
Evidence for evolutionary conservation of sex-determining genesC S Raymond, C E Shamu, M M Shen, et al.
Diabetes Care|June 2, 2000
Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 DiabetesR E Ratner, I B Hirsch, J L Neifing, et al.
Journal of Diabetes Science and Technology|April 16, 2016
Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study)Marcus Lind, William Polonsky, Irl B Hirsch, et al.
Metabolism: Clinical and Experimental|September 14, 2001
Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetesR Juneja, I B Hirsch, R G Naik, et al.
The Journal of Infectious Diseases|December 18, 2012
Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniaeElizabeth B Hirsch, Beining Guo, Kai-Tai Chang, et al.
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|July 21, 2012
The impact of inpatient point-of-care blood glucose quality control testingDawn E Corl, Tom S Yin, Andrew N Hoofnagle, et al.
Diabetes, Obesity & Metabolism|September 12, 2024
Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real-world analysisSatish K Garg, Irl B Hirsch, Enrico Repetto, et al.
Pageof 69

Showing results (391-400 of 686) with videos related to

Sort By:
Pageof 69
Transplantation and Cellular Therapy|January 19, 2024
Differential Association between Blood Glucose Levels and Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation Based on Presence or Absence of Preexisting DiabetesNahid Rashid, Ted Gooley, Michael Boeckh, et al.
Diabetes Care|February 1, 1990
Failure of nocturnal hypoglycemia to cause daytime hyperglycemia in patients with IDDMI B Hirsch, L J Smith, C E Havlin, et al.
Diagnostic Microbiology and Infectious Disease|November 8, 2011
A model to predict mortality following Pseudomonas aeruginosa bacteremiaElizabeth B Hirsch, Jessica M Cottreau, Kai-Tai Chang, et al.
Nature|March 7, 1998
Evidence for evolutionary conservation of sex-determining genesC S Raymond, C E Shamu, M M Shen, et al.
Diabetes Care|June 2, 2000
Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 DiabetesR E Ratner, I B Hirsch, J L Neifing, et al.
Journal of Diabetes Science and Technology|April 16, 2016
Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study)Marcus Lind, William Polonsky, Irl B Hirsch, et al.
Metabolism: Clinical and Experimental|September 14, 2001
Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetesR Juneja, I B Hirsch, R G Naik, et al.
The Journal of Infectious Diseases|December 18, 2012
Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniaeElizabeth B Hirsch, Beining Guo, Kai-Tai Chang, et al.
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|July 21, 2012
The impact of inpatient point-of-care blood glucose quality control testingDawn E Corl, Tom S Yin, Andrew N Hoofnagle, et al.
Diabetes, Obesity & Metabolism|September 12, 2024
Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real-world analysisSatish K Garg, Irl B Hirsch, Enrico Repetto, et al.
Pageof 69